Adam, Felicia; Fluri, Muriel; Scherz, Amina; Rabaglio, Manuela (2023). Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study. BMC medical genomics, 16(1), p. 7. BioMed Central 10.1186/s12920-023-01437-7
|
Text
s12920-023-01437-7.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
BACKGROUND AND PURPOSE
Over the last decade, the implementation of multigene panels for hereditary tumor syndrome has increased at our institution (Inselspital, University Hospital Berne, Switzerland). The aim of this study was to determine the prevalence of variants of unknown significance (VUS) in patients with suspected Lynch syndrome and suspected hereditary breast and ovarian cancer syndrome, the latter in connection with the trend toward ordering larger gene panels.
RESULTS
Retrospectively collected data from 1057 patients at our institution showed at least one VUS in 126 different cases (11.9%). In patients undergoing genetic testing for BRCA1/2, the prevalence of VUS was 6%. When < 10 additional genes were tested in addition to BRCA1/2, the prevalence increased to 13.8%, and 31.8% for > 10 additional genes, respectively. The gene most frequently affected with a VUS was ATM. 6% of our patients who were tested for Lynch syndrome had a VUS result in either MLH1, MSH2 or MSH6.
CONCLUSIONS
Our data demonstrate that panel testing statistically significantly increases VUS rates due to variants in non-BRCA genes. Good genetic counseling before and after obtaining results is therefore particularly important when conducting multigene panels to minimize patient uncertainty due to VUS results.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Scherz, Amina, Rabaglio, Manuela Elena |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1755-8794 |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
25 Jan 2023 15:44 |
Last Modified: |
25 Mar 2024 09:18 |
Publisher DOI: |
10.1186/s12920-023-01437-7 |
PubMed ID: |
36647026 |
Uncontrolled Keywords: |
BRCA1 BRCA2 Hereditary breast and ovarian cancer Lynch syndrome MMR genes Multigene panel VUS |
BORIS DOI: |
10.48350/177506 |
URI: |
https://boris.unibe.ch/id/eprint/177506 |
Actions (login required)
 |
Edit item |